Janssen Demonstrates Strong Commitment to Inflammatory Bowel Disease with Data from 25 Abstracts Presented at the 2019 Digestive Disease Week Annual Meeting

Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news